Caris Life Sciences (CAI) Accounts Payables (2024 - 2026)
Caris Life Sciences (CAI) posted quarterly Accounts Payables of $69.8 million for Q1 2026, up 78.04% quarter-over-quarter from $39.2 million in Q4 2025.
Caris Life Sciences (CAI) Accounts Payables (2024 - 2026) Analysis & Trends
Caris Life Sciences' Accounts Payables history runs 3 years deep, the most recent figure standing at $69.8 million for Q1 2026.
- In Q1 2026, Accounts Payables changed N/A year-over-year to $69.8 million; the TTM figure through Mar 2026 stood at $69.8 million (changed N/A YoY), while the FY2025 annual figure was $39.2 million, up 41.07% from the prior year.
- Accounts Payables for Q1 2026 stood at $69.8 million, up from $39.2 million in the prior quarter.
- The five-year high for Accounts Payables was $69.8 million in Q1 2026, with the low at $27.8 million in Q4 2024.
- The 3-year median for Accounts Payables is $29.0 million (2025), against an average of $38.9 million.
- Peak annual rise in Accounts Payables reached 41.07% in 2025, while the deepest fall reached 41.07% in 2025.
- Caris Life Sciences' Accounts Payables stood at $27.8 million in 2024, then jumped by 41.07% to $39.2 million in 2025, then jumped by 78.04% to $69.8 million in 2026.
- Business Quant data shows CAI's Accounts Payables at $69.8 million in Q1 2026, $39.2 million in Q4 2025, and $29.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 429.50 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 1.16 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.52 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 88.42 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 470.30 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 3.05 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 35.57 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 108.02 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 428.93 Mn |
| 10 | Caris Life Sciences | 6.16 Bn | 5.37 Bn | 182.38 Mn | 85.99 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 85.99 Mn |
| Mar 31, 2026 | 69.80 Mn |
| Dec 31, 2025 | 39.21 Mn |
| Sep 30, 2025 | 29.00 Mn |
| Jun 30, 2025 | 28.73 Mn |
| Dec 31, 2024 | 27.79 Mn |